Document 0119
 DOCN  M9470119
 TI    [Treatment of patients with acquired (non-HIV) immune deficiencies]
 DT    9409
 AU    Wilhelm M; Tony HP; Medizinische Poliklinik, Universitat Wurzburg.
 SO    Fortschr Med. 1994 Mar 30;112(9):117-21. Unique Identifier : AIDSLINE
       MED/94252646
 AB    Infection continues to remain a major problem in immunodeficient
       patients. The spectrum of pathogens differs, depending on whether one is
       dealing with an unspecific immune defect or a specific hormonal or
       cellular defect. This means that a knowledge of the type of deficiency
       presenting is of importance for the empirical treatment that is often
       required. Infection can be prevented by the replacement of
       immunoglobulins, in particular in the case of hormonal immune defects.
       The use of cytokines holds out some promise of achieving a similar
       effect in the treatment of cellular immune defects.
 DE    Combined Modality Therapy  English Abstract  Human  Immunity,
       Cellular/IMMUNOLOGY  Immunologic Deficiency
       Syndromes/ETIOLOGY/IMMUNOLOGY/*THERAPY  Opportunistic
       Infections/ETIOLOGY/IMMUNOLOGY/THERAPY  Risk Factors  JOURNAL ARTICLE
       REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).